Chief of Urology, Huntington Hospital
Urology
Dr. Christopher J. DiBlasio, MD
|
|
Give Review
Christopher J. DiBlasio, MD is an expert in the field of Urology. He went to St. George's University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification", "Alpha Omega Alpha (AOA) National Medical Honor Society", "George P. Murphy Honorary Scholar", "Physician Recognition Award for Excellence in Patient Care", "Musical Excellence Award; Most Valuable Player", "Peer-Distinguished Future Physician Award", "Deans List of Distinguished Academic Achievement", "Alpha Epsilon Delta (Pre-medical Honor Society)", "Alpha Mu Gamma (Foreign Language Honor Society; Italian)", "National Deans List", "All-American Scholar Award", "Four-Year Academic Merit-Based Scholarship Recipient", "Iota Epsilon Alpha (International Medical Honor Society; AOA equivalent)" and "Deans List of Distinguished Students". Christopher J. DiBlasio is a published MD. He has 32 papers published. The most current publication "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Dr. Christopher J. DiBlasio is registered with Medicare.
Publications
- Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for Renal tumors.
- Sutureless laparoscopic heminephrectomy: safety and efficacy in physiologic and Chronically obstructed porcine kidney.
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate Cancer.
- Postoperative nomogram predicting the 10-year probability of prostate Cancer recurrence after radical prostatectomy.
- Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate Cancer after radiotherapy.
- Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate Carcinoma treated with radical...
- Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate Cancer after radiation therapy.
- Ketorolac: safe and effective analgesia for the management of Renal cortical tumors with partial nephrectomy.
- Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
- Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate Cancer.
- Salvage radical prostatectomy for recurrence of prostate Cancer after radiation therapy.
- Male infertility on the internet: an analysis of web-based resources.
- Comparison of rates and risk factors for developing Chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy.
- Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate Cancer: 20-year single-centre experi...
- Adverse effects of androgen deprivation therapy in prostate Cancer: Current management issues.
- Peyronie''s Disease compromises the durability and component-malfunction rates in patients implanted with an inflatable penile prosthesis.
- Variation in the incidence of and risk factors for the development of nephrolithiasis after radical or partial nephrectomy.
- Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.
- Tubeless percutaneous nephrolithotomy for complex Renal stone disease: single center experience.
- Nonoperative management of blunt Renal trauma: is routine early follow-up imaging necessary?
- Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate Cancer.
- Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate Cancer.
- Osteoporosis and fractures after androgen deprivation initiation for prostate Cancer.
- Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate Cancer.
- Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate Cancer.
- Mini-flank supra-11th rib incision for open partial or radical nephrectomy.
- The role of endoluminal ultrasonography in urology: current perspectives.
- The chronology of depression and distress in men with Peyronie's Disease.
- Prognostic factors for survival in patients with hormone-refractory prostate Cancer (HRPC) after initial androgen deprivation therapy (ADT).
- Predicting clinical end points: treatment nomograms in prostate Cancer.
- Development and validation of a new treatment outcome score for men with LUTS.
Schools
St George39s University School Of Med St George39s Grenada
University Of Tennessee Health Science Center Memphis
Memorial SloanKettering Cancer Center
Fairfield University
Procedures Preformed
- AdRenalectomy
- Advanced Laparoscopic Surgery
- Bladder Function Test
- Bladder Repair Surgery
- View All
Conditions Treated
- Anemia
- Atrophic Vaginitis
- Balanoposthitis
- Bedwetting
- View All
Doctors Specialties
- Female Adult Urology
- Urologic Oncology
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Alpha Omega Alpha (AOA) National Medical Honor Society
- George P. Murphy Honorary Scholar
- Physician Recognition Award for Excellence in Patient Care
- Musical Excellence Award; Most Valuable Player
- Peer-Distinguished Future Physician Award
- Dean’s List of Distinguished Academic Achievement
- Alpha Epsilon Delta (Pre-medical Honor Society)
- Alpha Mu Gamma (Foreign Language Honor Society; Italian)
- National Dean’s List
- All-American Scholar Award
- Four-Year Academic Merit-Based Scholarship Recipient
- Iota Epsilon Alpha (International Medical Honor Society; AOA equivalent)
- Dean’s List of Distinguished Students
Education
-
University of Tennessee -
Memorial Sloan-Kettering Cancer Center -
St. George's University School of Medicine
Hospital
-
Huntington Hospital -
Mount Sinai Hospital -
North Shore University Hospital -
Long Island Jewish Medical Center
Drug Facts
| NPI NUMBER | 1952524274 | |
| NPPES Provider LastName | DIBLASIO | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 117432538 | |
| NPPES Provider State | NY | |
| Specialty Description | Urology | |
| Total Claim Count | 1751.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 41.0 | |
| Percent Opioid Claims | 2.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952524274 |
| Last Name Of The Provider | DIBLASIO |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
Dr. Ferdinand C. Diblasio, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas E. Spears, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony L. Reda Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles T. Hennings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan A. Newman, MD |
|
Dr. Kip L. Bodi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Shannon, MD
This Doctor is OpenDoctor Recommended.
|